… Larry Ellison’s Oracle Investment Management invested $7.5 million; the remainder comes from an issuance of ordinary shares.
… Part of the deal is to upgrade Mazor Robotic‘s Israeli ADR to be listed on the American NASDAQ.
… Mazor sales are rising steadily as more hospitals are acquiring their Renaissance™ spine surgery/implant system. Second quarter financial results reflect a four-fold increase from a year ago. “We have made significant progress in placing our Renaissance systems in prestigious hospital networks, particularly within the important U.S. market,” says company CEO.
… Medrobotics, a robotic surgical products company making cardioARM, a robotic probe controlled remotely and designed to enable surgeries with minimal or no incisions, filed an $8M round of equity, warrants and other options as part of a $20 million Series D offering. A total of 18 investors participated.